Close

Flexion Therapeutics (FLXN) Buys Novel, Non-Opioid Asset for Osteoarthritis of the Knee

December 13, 2017 4:06 PM EST Send to a Friend
Flexion Therapeutics, Inc. (Nasdaq: FLXN) today announced it has entered into a definitive agreement with GeneQuine Biotherapeutics GmbH to acquire ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login